SCS-4895354-6/10003/1

Boehringer Ingelheim RCV GmbH & Co KG — FEI 3003433722

Refusal Details

Date
October 28, 2025
Country
Austria
Product Category
Drugs and Biologics
Product Code
61PCA73 EMPAGLIFLOZIN (ANTI-DIABETIC)
Charges
118